Sambu Construction, currently under a trading suspension, has extended the termination date of its single sales and supply contract by more than one year and six months. Rehabilitation proceedings and a pre-approval M&A are also being pursued simultaneously.

In a corrective disclosure on the 16th, Sambu Construction announced that the termination date of the single sales and supply contract signed in December 2025 has been changed from June 22, 2026, to December 31, 2027. The company explained that this measure is a correction following the change in the contract termination date. Key terms such as the counterparty and contract amount remain unchanged, with only the contract period adjusted.

Meanwhile, Sambu Construction is pursuing a pre-approval M&A alongside its rehabilitation proceedings. In a corrective disclosure on the 19th, the company stated that the contracting party for the pre-approval M&A investment agreement has been changed. The originally intended acquirer, the Pareto Asset Management consortium, established a special purpose company (SPC) named Rebuild Sambu Holdings, and the Seoul Rehabilitation Court approved the change of this entity as the new party to the investment agreement. Accordingly, Rebuild Sambu Holdings will continue the acquisition process for Sambu Construction.

The total investment agreement amounts to 33 billion won. Both the deposit of 3.3 billion won and the balance of 29.7 billion won have been fully paid and pledged.

Additionally, the date for the meeting of interested parties to review the rehabilitation plan has been set for the 26th. The outcome of the meeting and the court's approval decision are expected to serve as key turning points in Sambu Construction's rehabilitation process. The market expects that the extension of the supply contract performance period and the progress of the pre-approval M&A will have a significant impact on the company's future normalization process.

As relevant details may change depending on the rehabilitation proceedings, M&A, and court approval results, it is necessary to thoroughly review the disclosures.